** Shares of E-commerce pharmaceutical firm Alibaba Health
Information Technology Ltd 0241.HK lead gains among Hong
Kong-listed information technology firms, sending the technology
sub-index .HSCIIT to its highest in nearly four months
** The Hang Seng sub-index tracking information technology
firms .HSCIIT climbs nearly 2 pct to 10,939.16, the highest
since Oct 3, 2018
** Shares of Alibaba Health climb as much as 6.8 pct to
HK$7.25, their highest since Dec 3, 2018
** Alibaba Health's parent Alibaba Group Holding Ltd
BABA.N posted quarterly profit far above market expectations
and played down worries of Chinese economic slowdown and U.S.
tariff effects urn:newsml:reuters.com:*:nL5N1ZU8XR
** Alibaba Group's earnings results, which is often seen as
a yardstick of consumer spending in the world's second-largest
economy, are likely to ease some worries on weak results among
chipmakers and tech firms
** Daiwa maintains "buy" on Alibaba Group, and raises target
price to $200 from $190, says Alibaba is the sector top-pick as
its solid fundamentals are relatively resilient against the
macro slowdown
** Among Hong Kong-listed technology-related firms, Meituan
3690.HK rises as much as 5.3 pct, Meitu 1357.HK climbs up to
3.5 pct, ZTE 0763.HK gains as much as 2.5 pct, and Tencent
0700.HK is up 1.1 pct
** The Hang Seng China enterprises index .HSCE climbs 1.5
pct, and the benchmark index .HSI is 1.1 pct higher
** China's main stock index CSI300 .CSI300 rises as much
as 1.2 pct
(Reuters Messaging: donny.kwok.thomsonreuters.com@reuters.net)